Cargando…
Recent advances in combinatorial drug screening and synergy scoring
Treatment of complex diseases such as cancer, cardiovascular disease, diabetes or neurological disorders frequently warrants the utilization of drug combinations for therapeutic intervention. In fact, the most successful example is the current standard of care for HIV patients. However, identificati...
Autores principales: | Pemovska, Tea, Bigenzahn, Johannes W, Superti-Furga, Giulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219891/ https://www.ncbi.nlm.nih.gov/pubmed/30193150 http://dx.doi.org/10.1016/j.coph.2018.07.008 |
Ejemplares similares
-
Metabolic drug survey highlights cancer cell dependencies and vulnerabilities
por: Pemovska, Tea, et al.
Publicado: (2021) -
Recent advances in combinatorial biosynthesis for drug discovery
por: Sun, Huihua, et al.
Publicado: (2015) -
In silico Prioritization of Transporter–Drug Relationships From Drug Sensitivity Screens
por: César-Razquin, Adrián, et al.
Publicado: (2018) -
Identifying Kinase Substrates via a Heavy ATP Kinase Assay and Quantitative Mass Spectrometry
por: Müller, André C., et al.
Publicado: (2016) -
Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
por: Hantschel, Oliver, et al.
Publicado: (2011)